Merck

See the following -

Apple Just Hired a Guy Who Could Completely Re-Invent the Company

Kif Leswing | Business Insider | June 23, 2016

Apple is quietly building one of the strongest teams in digital health, and on Thursday, it just added perhaps its most high-profile hire yet. Stephen Friend, co-founder and President of Sage Bionetworks, is joining Apple's healthcare team, Sage Bionetworks announced on Thursday. Apple said it had “nothing more to share about his role or title." Before Sage, Friend was an executive at Merck and a faculty member at Harvard Medical School...

Read More »

Chinese Melamine and American Vioxx: A Comparison

Ron Unz | The American Conservative | April 18, 2012

In contrasting China and America, pundits often cite our free and independent media as one of our greatest strengths, together with the tremendous importance which our society places upon individual American lives. For us, a single wrongful death can sometimes provoke weeks of massive media coverage and galvanize the nation into corrective action, while life remains cheap in China, a far poorer land of over a billion people, ruled by a ruthless Communist Party eager to bury its mistakes. But an examination of two of the greatest public-health scandals of the last few years casts serious doubt on this widespread belief.

Read More »

DocGraph Launches Linea

Press Release | DocGraph | June 1, 2015

DocGraph is launching a new web based portal Linea (http://www.docgraph.org/linea) to enable the health data science community to discover, aggregate and enrich new open healthcare datasets. DocGraph Linea is based on technology developed and contributed by Merck (known as MSD outside the United States and Canada). DocGraph Linea will provide data scientists a socially-enabled community open data platform that collects details about disparate healthcare datasets, and further allows the community to extend what data is available. Users will be able to search datasets, understand data lineage, view relationship matrices, add metadata, and see community algorithms.

Read More »

Doctors Promoting Treatments on Social Media Routinely Fail to Disclose Ties to Drug Makers

Sheila Kaplan | STAT | February 29, 2016

Physicians across the United States routinely offer medical advice on social media — but often fail to mention that they have accepted tens and sometimes hundreds of thousands of dollars from the companies that make the prescription drugs they tout. A STAT examination of hundreds of social media accounts shows that health care professionals virtually never note their conflicts of interest, some of them significant, when promoting drugs or medical devices on sites such as Facebook, Instagram, and Twitter. The practice cuts across all specialties...

Read More »

Drugs You Don't Need For Disorders You Don't Have

Jonathon Cohn | The Huffington Post | March 31, 2016

One evening in the late summer of 2015, Lisa Schwartz was watching television at her Vermont home when an ad for a sleeping pill called Belsomra appeared on the screen. Schwartz, a longtime professor at Dartmouth Medical College, usually muted commercials, but she watched this one closely: a 90-second spot featuring a young woman and two slightly cute, slightly creepy fuzzy animals in the shape of the words “sleep” and “wake”...

Read More »

European Bioinformatics Institute (EMBL-EBI) ChEMBL 20 incorporates the Pistoia Alliance’s HELM annotation

Press Release | Pistoia Alliance, European Bioinformatics Institute | February 3, 2015

The European Bioinformatics Institute (EMBL-EBI) has released version 20 of ChEMBL, the database of compound bioactivity data and drug targets. ChEMBL now incorporates the Hierarchical Editing Language for Macromolecules (HELM), the macromolecular representation standard recently released by the Pistoia Alliance.

Read More »

From Open Source to Open Science

Kevin Lustig | pharmaphorum | August 17, 2012

Kevin Lustig explores open science and how it can be used to increase access to scientific data. Kevin also looks at how pharmaceutical companies, such as Pfizer and Merck, are promoting their own brand of open science. Read More »

Is the American Heart Association a Terrorist Organization?

Kevin Michael Geary | Medium | June 21, 2017

A few days ago, the AHA stole the attention of headlines across the globe with a report that sounded like it was straight out of the 1990s: Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. In this report, the AHA doubled down on their attacks against coconut oil and saturated fat. Frank Sacks, lead author on the report, reportedly said that he has no idea why people think coconut oil is healthy...

Read More »

Low-Carb on Trial (Galileo Had It Easy)

Nora Gedgaudas | Primal Body Primal Mind | November 14, 2016

A recent exposé in the New York Times[1] revealed massive and pervasive fraud and collusion between the sugar industry and certain medical authorities in the 1960’s designed to erroneously promote saturated fat as the culprit behind heart disease. Effectively diverting attention from the real source of the problem (the increasing consumption of dietary sugar), the food industry conspired with key authorities within the medical establishment to serve their own best interests at the expense of public health.  Historic documents showed that they were intentionally concealing the fact that sugar, instead of fat, was knowingly to blame...

Read More »

Merck 'Evergreens' Off-Patent Lipitor By Creating Combination Drug With No Additional Benefit

Glyn Moody | Techdirt | July 8, 2013

Big pharma often gets a rather rough ride here on Techdirt, what with its attempts to stop governments granting licenses for life-saving and low-cost generics in emerging countries, engaging in legal action to prevent drug safety information being released, and paying kickbacks to doctors. Read More »

NY Attorney General Confirms Real-Life Conspiracy Among Drug Companies

J.D. Heyes | Natural News | February 21, 2014

The office of the New York Attorney General and the American units of Ranbaxy Laboratories Ltd. and Teva Pharmaceutical Industries Ltd. have come to terms on a settlement involving claims that an agreement between the two Big Pharma companies restricted competition unlawfully. Read More »

Pharma, Data Veteran Stephen Friend Bites At Apple’s Health Offer

Alex Lash | Xconomy | June 23, 2016

Consumer tech giant Apple, which has spent considerable effort positioning its products as health and fitness helpers, has just hired someone who knows Big Pharma and Big Data. Stephen Friend, a veteran of drug R&D and, more recently, a nonprofit effort to foster more collaborative biomedical research and more data sharing, is joining Apple in an unspecified capacity. The news emerged today from Sage Bionetworks, the Seattle nonprofit that Friend founded after leaving drug giant Merck, where he was a senior research executive for eight years...

Read More »

StayWell Adds SMART on FHIR App to Krames CareEngage Solution, Increasing Integration Capabilities Across Care Systems

Press Release | StayWell Company | February 21, 2017

The StayWell Company announced today that Krames CareEngageTM powered by Doctella now features a SMART on FHIR application. The SMART on FHIR application is available for testing with clients who use CareEngage for patient education and care management. StayWell will demonstrate the CareEngage solution during #HiMSS17 at booth 3443. CareEngage is an interactive platform that addresses real-world health needs, such as patient compliance and chronic conditions, by keeping patients better informed and engaged in their care...

Read More »

The Evolving Landscape Of Medical Apps In Healthcare

Jasmine Pennic | HIT Consultant | June 23, 2014

Mitchell Posada, VP of Marketing at Pathfinder Software discusses the evolving landscape of medical apps in healthcare...

Read More »

Timeline: How Apple Is Piecing Together its Secret Healthcare Plan

Bill Siwicki | Healthcare IT News | June 23, 2017

Rumors are at a fever pitch that Apple has big plans for healthcare, including putting a medical record on the iPhone, possibly acquiring its way into the EHR market. From its leap into healthcare in 2014 with its HealthKit application programming interface in September 2014 to the June 19 revelation of Apple’s work with the tiny start-up Health Gorilla, Apple has made a series of moves in healthcare that clearly indicate the company has plans for the space that will somehow manifest on its mega-popular iPhone and iPad products. Here’s a look at how Apple got to where it is today in healthcare...

Read More »